These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 34245331)
1. Fibroblast Growth Factor 2 High Molecular Weight Isoforms in Dentoalveolar Mineralization. Millington G; Joseph J; Xiao L; Vijaykumar A; Mina M; Hurley MM Calcif Tissue Int; 2022 Jan; 110(1):93-103. PubMed ID: 34245331 [TBL] [Abstract][Full Text] [Related]
2. FGF23 Neutralizing Antibody Partially Improves Bone Mineralization Defect of HMWFGF2 Isoforms in Transgenic Female Mice. Xiao L; Homer-Bouthiette C; Hurley MM J Bone Miner Res; 2018 Jul; 33(7):1347-1361. PubMed ID: 29502359 [TBL] [Abstract][Full Text] [Related]
3. FGF23 Neutralizing Antibody Ameliorates Hypophosphatemia and Impaired FGF Receptor Signaling in Kidneys of HMWFGF2 Transgenic Mice. Du E; Xiao L; Hurley MM J Cell Physiol; 2017 Mar; 232(3):610-616. PubMed ID: 27306296 [TBL] [Abstract][Full Text] [Related]
4. Effects of Active Vitamin D or FGF23 Antibody on Lira Dos Santos EJ; Chavez MB; Tan MH; Mohamed FF; Kolli TN; Foster BL; Liu ES J Dent Res; 2021 Dec; 100(13):1482-1491. PubMed ID: 33906518 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of FGFR Signaling Partially Rescues Hypophosphatemic Rickets in HMWFGF2 Tg Male Mice. Xiao L; Du E; Homer-Bouthiette C; Hurley MM Endocrinology; 2017 Oct; 158(10):3629-3646. PubMed ID: 28938491 [TBL] [Abstract][Full Text] [Related]
7. Nuclear fibroblast growth factor 2 (FGF2) isoforms inhibit bone marrow stromal cell mineralization through FGF23/FGFR/MAPK in vitro. Xiao L; Esliger A; Hurley MM J Bone Miner Res; 2013 Jan; 28(1):35-45. PubMed ID: 22836867 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of FGFR Signaling Partially Rescues Osteoarthritis in Mice Overexpressing High Molecular Weight FGF2 Isoforms. Xiao L; Williams D; Hurley MM Endocrinology; 2020 Jan; 161(1):. PubMed ID: 31901095 [TBL] [Abstract][Full Text] [Related]
9. Dental impact of anti-fibroblast growth factor 23 therapy in X-linked hypophosphatemia. Lira Dos Santos EJ; Nakajima K; Po J; Hanai A; Zhukouskaya V; Biosse Duplan M; Linglart A; Shimada T; Chaussain C; Bardet C Int J Oral Sci; 2023 Dec; 15(1):53. PubMed ID: 38052774 [TBL] [Abstract][Full Text] [Related]
10. FGFR Inhibitor Ameliorates Hypophosphatemia and Impaired Engrailed-1/Wnt Signaling in FGF2 High Molecular Weight Isoform Transgenic Mice. Du E; Xiao L; Hurley MM J Cell Biochem; 2016 Sep; 117(9):1991-2000. PubMed ID: 26762209 [TBL] [Abstract][Full Text] [Related]
11. Dentoalveolar Defects in the Zhang H; Chavez MB; Kolli TN; Tan MH; Fong H; Chu EY; Li Y; Ren X; Watanabe K; Kim DG; Foster BL J Dent Res; 2020 Apr; 99(4):419-428. PubMed ID: 31977267 [TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factor 23 overexpression impacts negatively on dentin mineralization and dentinogenesis in mice. Chen L; Liu H; Sun W; Bai X; Karaplis AC; Goltzman D; Miao D Clin Exp Pharmacol Physiol; 2011 Jun; 38(6):395-402. PubMed ID: 21488937 [TBL] [Abstract][Full Text] [Related]
13. FGF2 High Molecular Weight Isoforms Contribute to Osteoarthropathy in Male Mice. Meo Burt P; Xiao L; Dealy C; Fisher MC; Hurley MM Endocrinology; 2016 Dec; 157(12):4602-4614. PubMed ID: 27732085 [TBL] [Abstract][Full Text] [Related]
14. Comparison of calcimimetic R568 and calcitriol in mineral homeostasis in the Hyp mouse, a murine homolog of X-linked hypophosphatemia. Leifheit-Nestler M; Kucka J; Yoshizawa E; Behets G; D'Haese P; Bergen C; Meier M; Fischer DC; Haffner D Bone; 2017 Oct; 103():224-232. PubMed ID: 28728941 [TBL] [Abstract][Full Text] [Related]
15. 1,25-Dihydroxyvitamin D Alone Improves Skeletal Growth, Microarchitecture, and Strength in a Murine Model of XLH, Despite Enhanced FGF23 Expression. Liu ES; Martins JS; Raimann A; Chae BT; Brooks DJ; Jorgetti V; Bouxsein ML; Demay MB J Bone Miner Res; 2016 May; 31(5):929-39. PubMed ID: 26751835 [TBL] [Abstract][Full Text] [Related]